Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000327

Options or other derivatives

  • Chief Business - Strategy Off acquired 106,648 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lin Patrick Chief Business - Strategy Off 2022-12-31 Grant or award · Restricted Stock Units +10,851 344,531 D: show line 1 in the form
Lin Patrick Chief Business - Strategy Off 2023-01-01 Grant or award · Restricted Stock Units +55,107 399,638 D: show line 2 in the form
Lin Patrick Chief Business - Strategy Off 2023-01-01 Grant or award · Restricted Stock Units +40,690 440,328 D: show line 3 in the form
Loading xslF345X03/doc1.xml…